Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Symbotic | SYM | Nov 15, 2024 | 29.49 | -1.47 |
Synaptics | SYNA | Nov 15, 2024 | 74.64 | -0.80 |
Synaptogenix | SNPX | Nov 15, 2024 | 2.40 | -8.05 |
Synchronoss Technologies | SNCR | Nov 15, 2024 | 8.95 | -0.11 |
Synchrony Financial | SYF | Nov 15, 2024 | 64.98 | +0.14 |
Synchrony Financial Pref A | SYF-A | Nov 15, 2024 | 20.48 | +0.89 |
Synchrony Financial Pref A | SYF-B | Nov 15, 2024 | 26.37 | -0.49 |
Syndax Pharmaceuticals | SNDX | Nov 15, 2024 | 15.83 | -5.72 |
Synergetics Inc | FTGC | Nov 15, 2024 | 23.26 | +0.04 |
Synergy CHC | SNYR | Nov 15, 2024 | 6.36 | 0.00 |
Synlogic | SYBX | Nov 15, 2024 | 1.36 | -2.15 |
Synopsys | SNPS | Nov 15, 2024 | 520.75 | -5.03 |
Synovus Financial | SNV | Nov 15, 2024 | 55.72 | +0.09 |
Synovus Financial D Pref | SNV-D | Nov 15, 2024 | 25.37 | -0.12 |
Synovus Financial E Pref | SNV-E | Nov 15, 2024 | 26.38 | -0.26 |
Syntec Optics | OPTX | Nov 15, 2024 | 1.04 | -31.13 |
Sypris Solutions | SYPR | Nov 15, 2024 | 1.36 | -0.01 |
Syra Health | SYRA | Nov 15, 2024 | 0.36 | -4.08 |
Syros Pharmaceuticals | SYRS | Nov 15, 2024 | 0.26 | -5.74 |
Sysco | SYY | Nov 15, 2024 | 74.95 | -0.01 |
System1 A | SST | Nov 15, 2024 | 0.95 | -10.14 |
T Stamp A | IDAI | Nov 15, 2024 | 0.19 | -0.63 |
T-Mobile US | TMUS | Nov 15, 2024 | 235.61 | -0.90 |
T. Rowe Price Blue Chip Growth ETF | TCHP | Nov 15, 2024 | 41.08 | -2.33 |
T. Rowe Price Dividend Growth ETF | TDVG | Nov 15, 2024 | 40.63 | -1.00 |
T. Rowe Price Equity Income ETF | TEQI | Nov 15, 2024 | 42.47 | 0.00 |
T. Rowe Price Group | TROW | Nov 15, 2024 | 118.77 | -0.86 |
T. Rowe Price Growth Stock ETF | TGRW | Nov 15, 2024 | 38.92 | -2.31 |
T2 Biosystems | TTOO | Nov 15, 2024 | 0.50 | -4.42 |
Taboola.com | TBLA | Nov 15, 2024 | 3.14 | -1.88 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.